| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acquired and intrinsic resistance in cancer immunotherapy
|
Kelderman, Sander
|
|
2014
|
8 |
6 |
p. 1132-1139
8 p.
|
artikel
|
| 2 |
Acquired resistance to EGFR-targeted therapies in colorectal cancer
|
Van Emburgh, Beth O.
|
|
2014
|
8 |
6 |
p. 1084-1094
11 p.
|
artikel
|
| 3 |
Brain metastasis: New opportunities to tackle therapeutic resistance
|
Seoane, Joan
|
|
2014
|
8 |
6 |
p. 1120-1131
12 p.
|
artikel
|
| 4 |
Cancer drug resistance: Old concept, novel solutions required
|
Peeper, Daniel S.
|
|
2014
|
8 |
6 |
p. 1064-1066
3 p.
|
artikel
|
| 5 |
Drug resistance to targeted therapies: Déjà vu all over again
|
Groenendijk, Floris H.
|
|
2014
|
8 |
6 |
p. 1067-1083
17 p.
|
artikel
|
| 6 |
Editorial Board
|
|
|
2014
|
8 |
6 |
p. ii-
1 p.
|
artikel
|
| 7 |
Erratum to “Multi-level gene expression signatures, but not binary, outperform Ki67 for the long term prognostication of breast cancer patients” [MOLONC 8 (2014) 741–752]
|
Tobin, Nicholas P.
|
|
2014
|
8 |
6 |
p. 1159-
1 p.
|
artikel
|
| 8 |
New members of the editorial board – Personal profiles
|
Pedersen, Dorte Holst
|
|
2014
|
8 |
6 |
p. 1055-1056
2 p.
|
artikel
|
| 9 |
No longer an untreatable disease: How targeted and immunotherapies have changed the management of melanoma patients
|
Girotti, Maria Romina
|
|
2014
|
8 |
6 |
p. 1140-1158
19 p.
|
artikel
|
| 10 |
Reading between the lines; understanding drug response in the post genomic era
|
Alifrangis, Constantine C.
|
|
2014
|
8 |
6 |
p. 1112-1119
8 p.
|
artikel
|
| 11 |
The dream and reality of histology agnostic cancer clinical trials
|
Lacombe, Denis
|
|
2014
|
8 |
6 |
p. 1057-1063
7 p.
|
artikel
|
| 12 |
Tumour heterogeneity and the evolution of polyclonal drug resistance
|
Burrell, Rebecca A.
|
|
2014
|
8 |
6 |
p. 1095-1111
17 p.
|
artikel
|
Tijdschrift beschrijving